Here's why the EMvision share price surged 8% on Wednesday

Investors appear happy about an agreement EMvision has struck with tech company Keysight Technologies.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • EMvision shares are racing higher today following a company update
  • The company has entered into a strategic agreement with a long-term partner Keysight Technologies
  • In the last 12 months the EMvision share price has fallen more than 38%

The EMvision Medical Devices Ltd (ASX: EMV) share price has emerged from a trading halt on Wednesday morning, and shot 8% into the green.

Prior to their halt, EMVision shares closed at $1.94. Upon returning to trade, they have been sitting in the green amid the release of a company announcement. At the time of writing, EMvision shares are swapping hands at $2.05.

A guy wearing glasses tries to show off his muscles.

Image source: Getty Images

What did EMVision announce?

The company advised it has entered into an original equipment manufacturer (OEM) agreement with Keysight Technologies Inc (NYSE: KEYS).

According to the release, "Keysight is the world leader in radiofrequency (RF) test and measurement technology". Specifically, the company signed its agreement with Keysight's Australian subsidiary.

Under the agreement, EMvision will receive exclusive supply for 'fast sweep' features in the vector network analyser (VNA).

For reference, EMvision says the VNA is a custom solution developed in collaboration with Keysight.

"The VNA is a high performance, lower component count, miniaturised module responsible for accurate signal measurement," states the release.

"The custom VNA represents a strategic investment by Keysight into the electromagnetic imaging sector."

Regarding the announcement, EMvision CEO Dr Ron Weinberger says the collaboration "has been first class".

This Agreement recognises the roles that both parties have played in the development of the bespoke VNA over a period of 3 years. I would like to thank the Keysight team for their concerted work in developing a best-of-breed solution for EMvision and look forward to the commercial phase of our relationship.

Noteworthy is that Keysight is not a medical device manufacturer. However, it does possess "the strongest portfolio of Vector Network Analysers (VNA), which are core to the sensors that are being used inside EMvision's portable brain scanner," says the company.

The agreement builds on a relationship that spawned back in 2019. Then, the pair entered into a strategic collaboration to develop "custom healthcare-focused VNA solutions".

EMvision share price snapshot

In the last 12 months the EMvision share price has fallen more than 38%. Meanwhile, it is 23.5% in the red since trading resumed this year.

Following this announcement, shares have bounced from a low point and are tracking back towards monthly highs.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended EMvision Medical Devices Limited. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Technology Shares

A woman wearing yellow smiles and drinks coffee while on laptop.
Technology Shares

The ASX 200 shares I think smart investors are buying after the tech selloff

The recent pullback has changed the conversation around several ASX 200 growth shares.

Read more »

Smiling young parents with their daughter dream of success.
Technology Shares

Here's why Life360 shares could rise a massive 75%

Big returns could be coming for buyers of this tech stock according to Bell Potter.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Technology Shares

3 reasons to buy Xero shares now

This beaten down tech stock could be worth considering. Let's see why.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
52-Week Lows

Down 43% this year, this ASX tech stock is now back at January 2025 levels

Megaport shares are down 43% this year as weak momentum continues.

Read more »

A judge bangs down the gavel.
Technology Shares

Why are shares in this ASX defence company tanking today?

They've received more than just a slap on the wrist.

Read more »

A boy holds on tight as his gaming console nearly blows him away.
Technology Shares

This ASX tech firm presents a "unique" opportunity, Shaw and Partners says

A major game launch is just days away.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Technology Shares

DroneShield shares rebound on investor update

The counter-drone technology company has released an update.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Technology Shares

Should you buy the 20% dip in the DroneShield share price?

This high-flying stock is having its wings clipped on Wednesday.

Read more »